Contact Us
  Search
The Business Research Company Logo
Global Pollen Allergy Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Pollen Allergy Market Report 2026

Global Outlook – By Product Type (Instruments, Consumables, Services ), By Allergen Type (Environmental Allergens, Inhaled, Airborne Allergens, Other Allergen Types ), By Therapeutics Drug class (Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, Immunotherapy ), By End-User (Diagnostic Laboratories, Hospitals) - Market Size, Trends, And Global Forecast 2026-2035

Pollen Allergy Market Overview

• Pollen Allergy market size has reached to $7.49 billion in 2025 • Expected to grow to $10.94 billion in 2030 at a compound annual growth rate (CAGR) of 7.8% • Growth Driver: Prevalence Of Allergic Rhinitis Driving Increased Demand For Pollen Allergens • Market Trend: Innovative Allergy Care Platforms Transforming Diagnosis And Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pollen Allergy Market?

Pollen allergy is an allergic reaction to pollen from trees, grasses, and weeds. It occurs when the immune system mistakenly identifies pollen as harmful and releases chemicals such as histamine to combat it. Pollen allergies are often seasonal, peaking during spring, summer, or fall, depending on the pollen an individual is sensitive to. The main product types in the pollen allergy market include instruments, consumables, and services. Instruments refer to medical devices used for diagnosing, monitoring, and treating pollen allergies, such as nasal irrigation devices, allergy testing equipment, and inhalers. The types of allergens include food, inhaled, drug, and other allergens. Various treatments used for pollen allergies include antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, immunomodulators, auto-injectable epinephrine, and immunotherapy. These products are primarily used in diagnostic laboratories and hospitals.
Pollen Allergy Market Global Report 2026 Market Report bar graph

What Is The Pollen Allergy Market Size and Share 2026?

The pollen allergy market size has grown strongly in recent years. It will grow from $7.49 billion in 2025 to $8.09 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing prevalence of seasonal allergies, rising environmental pollen exposure, growth in allergy diagnostic services, availability of antihistamine medications, expansion of allergy awareness programs.

What Is The Pollen Allergy Market Growth Forecast?

The pollen allergy market size is expected to see strong growth in the next few years. It will grow to $10.94 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to growing adoption of immunotherapy treatments, rising investments in precision allergy diagnostics, increasing focus on preventive allergy care, expansion of biologic allergy treatments, growing integration of digital allergy monitoring tools. Major trends in the forecast period include increasing adoption of personalized allergy therapies, rising use of advanced diagnostic testing for allergens, growing demand for long-term immunotherapy solutions, expansion of seasonal allergy management programs, enhanced focus on early allergy diagnosis.
Research Expert

Book your 30 minutes free consultation with our research experts

Global Pollen Allergy Market Segmentation

1) By Product Type: Instruments, Consumables, Services 2) By Allergen Type: Environmental Allergens, Inhaled, Airborne Allergens, Other Allergen Types 3) By Therapeutics Drug class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, Immunotherapy 4) By End-User: Diagnostic Laboratories, Hospitals Subsegments: 1) By Instruments: Allergy Testing Equipment, Diagnostic Devices, Monitoring Devices 2) By Consumables: Allergy Test Kits, Pollen Filters, Diagnostic Reagents, Treatment Medications (Antihistamines) 3) By Services: Allergy Testing Services, Immunotherapy Services, Consultation And Diagnostic Services

What Is The Driver Of The Pollen Allergy Market?

The prevalence of allergic rhinitis is expected to drive the growth of the pollen allergen market going forward. Allergic rhinitis is an allergic condition that inflames the nose, leading to sneezing, a blocked nose, and itchy eyes, usually caused by pollen or dust. The rise in allergic rhinitis is attributed to environmental pollution, climate change, urbanization, and lifestyle shifts, which increase exposure to allergens and pollutants. Allergic rhinitis is a common condition caused by pollen allergies, where exposure to pollen triggers inflammation in the nasal passages. For instance, in October 2023, according to the World Allergy Organization, a US-based umbrella organization for clinical allergic studies, allergic rhinitis impacts over 400 million people globally, with prevalence rates ranging from 10% to 30% in adults and exceeding 40% in children. Therefore, the rise in the prevalence of allergic rhinitis is driving the growth of the pollen allergen market.

Key Players In The Global Pollen Allergy Market

Major companies operating in the pollen allergy market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck KGaA, AbbVie Inc., Bayer AG, Sanofi SA, AstraZeneca Plc, Novartis AG, GlaxoSmithKline PLC, Astellas Pharma Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd, Genentech Inc., Omega Pharma, ALK Abello, Stallergenes Greer, Aimmune Therapeutics, Allergy Therapeutics, McNeil Consumer Healthcare, Meda Pharmaceuticals Inc, HAL Allergy Group, Allergopharma, Biomay AG, Leti Pharma, Alerpharma S.A

What Are Latest Mergers And Acquisitions In The Pollen Allergy Market?

In September 2023, Stallergenes Greer International AG, a Switzerland-based pharmaceutical company, acquired peanut allergy oral immunotherapy treatment Palforzia from Nestlé S.A for an undisclosed amount. This acquisition strengthens the Stallergenes’s position as a leader in allergen immunotherapy by expanding its offerings to include both respiratory and food allergy treatments. Nestlé S.A is a Switzerland-based food and beverage services company actively addressing various allergies, including food and environmental allergies, such as those related to pollen.

Regional Outlook

North America was the largest region in the pollen allergy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Pollen Allergy Market?

The pollen allergy market consists of sales of nasal sprays, eye drops, allergy masks, air purifiers, and pollen blockers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pollen Allergy Market Report 2026?

The pollen allergy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pollen allergy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Pollen Allergy Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$8.09 billion
Revenue Forecast In 2035$10.94 billion
Growth RateCAGR of 8.1% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredProduct Type, Allergen Type, Therapeutics Drug class, End-User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledJohnson & Johnson, F. Hoffmann-La Roche Ltd., Merck KGaA, AbbVie Inc., Bayer AG, Sanofi SA, AstraZeneca Plc, Novartis AG, GlaxoSmithKline PLC, Astellas Pharma Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd, Genentech Inc., Omega Pharma, ALK Abello, Stallergenes Greer, Aimmune Therapeutics, Allergy Therapeutics, McNeil Consumer Healthcare, Meda Pharmaceuticals Inc, HAL Allergy Group, Allergopharma, Biomay AG, Leti Pharma, Alerpharma S.A
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us